Agencia Española de Medicamentos y Productos Sanitarios
Impact in
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Venous Thromboembolism Diagnosis and Management 19
- Top scholars
- Francisco José de AbajoFerrán Catalá-LópezAgustı́n PortelaDigard PaulAntonio Gómez‐OutesLoreto CarmonaJuan Jesús Gómez-ReinoVicente Rodríguez Valverde
- Journals
- Pharmacoepidemiology and Drug Safety (27 papers)European Journal of Clinical Pharmacology (12 papers)Vaccine (11 papers)Drug Safety (10 papers)Revista Española de Cardiología (English Edition) (10 papers)
- Partner nations
- SpainNetherlandsGermany
In The Last Decade
Agencia Española de Medicamentos y Productos Sanitarios
394 papers receiving 7.5k citations
Peers
Comparison fields: 5 of 187
- Internal Medicine 466
- Applied Microbiology and Biotechnology 228
- Toxicology 319
- Cardiology and Cardiovascular Medicine 1.4k
- Molecular Medicine 325
Countries citing scholars working at Agencia Española de Medicamentos y Productos Sanitarios
This map shows the geographic impact of research produced by authors working at Agencia Española de Medicamentos y Productos Sanitarios. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Agencia Española de Medicamentos y Productos Sanitarios with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agencia Española de Medicamentos y Productos Sanitarios more than expected).
Fields of papers published by authors at Agencia Española de Medicamentos y Productos Sanitarios
This network shows the impact of papers affiliated with Agencia Española de Medicamentos y Productos Sanitarios at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Agencia Española de Medicamentos y Productos Sanitarios at the time of their publication.
About Agencia Española de Medicamentos y Productos Sanitarios
In recent decades, authors affiliated with Agencia Española de Medicamentos y Productos Sanitarios have published 510 papers, which have received a total of 10.7k indexed citations . Scholars at this organization have produced 11 papers in Applied Microbiology and Biotechnology, 19 papers in Internal Medicine, 14 papers in Geriatrics and Gerontology, 18 papers in Molecular Medicine and 12 papers in Toxicology on the topics of Health Systems, Economic Evaluations, Quality of Life (50 papers), Pharmaceutical Economics and Policy (30 papers), Pharmaceutical studies and practices (26 papers), Atrial Fibrillation Management and Outcomes (24 papers), Venous Thromboembolism Diagnosis and Management (19 papers), Biosimilars and Bioanalytical Methods (18 papers), Biomedical Ethics and Regulation (17 papers) and Drug Solubulity and Delivery Systems (17 papers). Their work is cited by papers focused on Internal Medicine (466 citations), Applied Microbiology and Biotechnology (228 citations), Toxicology (319 citations), Cardiology and Cardiovascular Medicine (1.4k citations) and Molecular Medicine (325 citations). Authors at Agencia Española de Medicamentos y Productos Sanitarios collaborate with scholars in Spain, Netherlands and Germany and have published in prestigious journals including Pharmacoepidemiology and Drug Safety, European Journal of Clinical Pharmacology, Vaccine, Drug Safety and Revista Española de Cardiología (English Edition). Some of Agencia Española de Medicamentos y Productos Sanitarios's most productive authors include Francisco José de Abajo, Ferrán Catalá-López, Agustı́n Portela, Digard Paul, Antonio Gómez‐Outes, Loreto Carmona, Juan Jesús Gómez-Reino, Vicente Rodríguez Valverde, Emilio Martín Mola and Emilio Vargas.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.